financetom
Business
financetom
/
Business
/
Jabil Buys Pharmaceutics International for Undisclosed Sum
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Jabil Buys Pharmaceutics International for Undisclosed Sum
Feb 4, 2025 6:35 AM

09:21 AM EST, 02/04/2025 (MT Newswires) -- Jabil ( JBL ) said Tuesday it has acquired Pharmaceutics International, a privately-held contract development and manufacturing organization that specializes in early stage, clinical and commercial volume aseptic filling, lyophilization and solid oral medication production in Hunt Valley, Maryland.

Financial terms and other details of the transaction that was completed on Monday were not disclosed.

JBL shares were 1.1% higher in recent premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Arista Recovery Expands into Ohio with Launch of New Hilliard Behavioral Health Campus
Arista Recovery Expands into Ohio with Launch of New Hilliard Behavioral Health Campus
Nov 13, 2025
New acquisition strengthens Arista Recovery's mission to expand access to high-quality, compassionate behavioral health care across the Midwest. COLUMBUS, Ohio, Nov. 13, 2025 /PRNewswire/ -- Arista Recovery, a nationally recognized leader in behavioral health treatment, proudly announces the launch of Arista Recovery – Hilliard, marking the organization's expansion into Ohio. Arista assumed operations of the Hilliard facility through an acquisition...
Form 8.3
Form 8.3
Nov 13, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Form 8.3
Form 8.3
Nov 13, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Form 8.3
Form 8.3
Nov 13, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved